Wang W, Wang S, Meng X, Zhao Y, et al. A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2. Antiviral Res 2024 Mar 4:105854. doi: 10.1016/j.antiviral.2024.105854.
PMID: 38447647